Siga Technologies INC Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31)
Siga Technologies INC (SIGA) reported Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31) of $6.37 million for the 1-month period ending 2016-04-29, per its 10-Q filed 2016-05-04.
Discontinued › Notes
us-gaap:LiabilitiesSubjectToCompromiseCashDisbursementsAndReclassificationIncreaseDecreaseUnderBankruptcyCourtOrderResolutionsOfContingenciesSubjectToChapter11 · last filed 2016-05-04
- 2016-04-29: Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31) 1 month $6.37M.
- 2016-04-12: Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31) $5.00M.
| Period end | Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31) | Liabilities Subject to Compromise, Cash Disbursements and Reclassification Increase (Decrease) under Bankruptcy Court Order, Resolutions of Contingencies Subject to Chapter 11 (Deprecated 2016-01-31) 1 month |
|---|---|---|
| 2016-04-29 | $6.37M 10-Q · filed 2016-05-04 | |
| 2016-04-12 | $5.00M 10-Q · filed 2016-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |